Year:

  1.  4
    The Future of the Pharmaceutical Industry: Beyond Government-Granted Monopolies.Dean Baker - 2021 - Journal of Law, Medicine and Ethics 49 (1):25-29.
    Just as tariffs lead to economic distortions and provide incentives for corruption, so do patent monopolies on prescription drugs, except the impact is often an order of magnitude larger.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  2.  2
    Disruptures in the Dental Ethos: The Birth, Life, & Neoliberal Retirement of Norms in Advertising & Corporatization.Na’eel Cajee - 2021 - Journal of Law, Medicine and Ethics 49 (1):77-88.
    This paper argues that the trends in advertising and corporatization in dentistry since the 1970s have resulted in processes of de-professionalization and de-regulation, respectively.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  3.  3
    The Boston Medical Center Immigrant Task Force: An Alternative to Teaching Immigration Law to Health Care Providers.Sondra S. Crosby, Lily Sonis & George J. Annas - 2021 - Journal of Law, Medicine and Ethics 49 (1):59-63.
    As healthcare providers engage in the politics of reforming and humanizing our immigration and asylum “system” it is critical that they are able to refer their patients whose health is directly impacted by our immigration laws and policies to experts who can help them navigate the system and obtain the healthcare they need.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  4.  2
    Letter From The Editor.Ted Hutchinson - 2021 - Journal of Law, Medicine and Ethics 49 (1):1-1.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  5.  2
    Regulation of Overlapping Surgery: Progress and Gaps.Elle L. Kalbfell & Margaret L. Schwarze - 2021 - Journal of Law, Medicine and Ethics 49 (1):74-76.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  6.  2
    Realizing Public Rights Through Government Patent Use.Amy Kapczynski - 2021 - Journal of Law, Medicine and Ethics 49 (1):34-38.
    A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public’s investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  7.  3
    Healthcare Professionals’ Experience, Training, and Knowledge Regarding Immigration-Related Law Enforcement in Healthcare Facilities: An Online Survey.Jaime La Charite, Derek W. Braverman, Dana Goplerud, Alexandra Norton, Amanda Bertram & Zackary D. Berger - 2021 - Journal of Law, Medicine and Ethics 49 (1):50-58.
    U.S. immigration policies and enforcement can make immigrants fearful of accessing healthcare. Although current immigration policies restrict enforcement in “sensitive locations” including healthcare facilities, there are reports of enforcement actions in such settings.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  2
    A Non-Profit Approach to Address Foreign Dependence of Generic Drugs.Dan Liljenquist, Ge Bai, Ameet Sarpatwari & Gerard F. Anderson - 2021 - Journal of Law, Medicine and Ethics 49 (1):30-33.
    The COVID-19 pandemic has revealed the vulnerability of the US generic drug supply chain to foreign production. Many policies have been proposed to mitigate this vulnerability. In this article, we argue that nonprofit drug manufacturers have the potential to make important contributions.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  9.  1
    Letter to the Editor.Kerry Lynn Macintosh, I. Glenn Cohen, Jacob S. Sherkow & Eli Y. Adashi - 2021 - Journal of Law, Medicine and Ethics 49 (1):156-157.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  10.  3
    Opportunities and Challenges in Translational Research: The Development of Photodynamic Therapy and Anti-Vascular Endothelial Growth Factor Drugs.Christina Kaiser Marko & Joan W. Miller - 2021 - Journal of Law, Medicine and Ethics 49 (1):19-24.
    The development of photodynamic therapy and anti-vascular endothelial growth factor agents have revolutionized the treatment of retinal diseases, transforming the retina subspecialty by ushering in an age of pharmacological treatments for a wide range of diseases, including age-related macular degeneration.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  11.  3
    A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest.Mariana Mazzucato & Henry Lishi Li - 2021 - Journal of Law, Medicine and Ethics 49 (1):39-49.
    Enhancing research and development and ensuring equitable pricing and access to cutting-edge treatments are both vital to a biopharmaceutical innovation system that works in the public interest. However, despite delivering numerous therapeutic advances, the existing system suffers from major problems: a lack of directionality to meet key needs, inefficient collaboration, high prices that fail to reflect the public contribution, and an overly-financialized business model.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  1
    A Survey of Overlapping Surgery Policies at U.S. Hospitals.Margaret B. Mitchell, Catherine M. Hammack-Aviran, Ellen W. Clayton & Alexander Langerman - 2021 - Journal of Law, Medicine and Ethics 49 (1):64-73.
    The authors surveyed hospitals across the country on their policies regarding overlapping surgery, and found large variation between hospitals in how this practice is regulated. Specifically, institutions chose to define “critical portions” in a variety of ways, ultimately affecting not only surgical efficiency but also the autonomy of surgical trainees and patient experiences at these different hospitals.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  5
    Improving the Ethical Review of Health Policy and Systems Research: Some Suggestions.Govind Persad - 2021 - Journal of Law, Medicine and Ethics 49 (1):123-125.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  14.  3
    Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France.Véronique Raimond, Julien Mousquès, Jerry Avorn & Aaron S. Kesselheim - 2021 - Journal of Law, Medicine and Ethics 49 (1):139-151.
    Based on hierarchical classification and logistic regression of early US and French COVID-19 clinical trials we show that despite the registration of a large number of trials, only a minority had characteristics usually associated with providing robust and relevant evidence.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  15.  3
    Operationalizing the Ethical Review of Global Health Policy and Systems Research: A Proposed Checklist.Abbas Rattani & Adnan A. Hyder - 2021 - Journal of Law, Medicine and Ethics 49 (1):92-122.
    There has been growing consensus to develop relevant guidance to improve the ethical review of global health policy and systems research and address the current absence of formal ethics guidance.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  16. Employer Liability for “Take-Home” COVID-19.Mark A. Rothstein & Julia Irzyk - 2021 - Journal of Law, Medicine and Ethics 49 (1):126-131.
    Workplace exposure to SARS-CoV-2 has sickened workers and, subsequently, their family members. Family members might be able to recover from the employer in a negligence action using “take-home” liability theory.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  17.  1
    The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead.Bhaven N. Sampat - 2021 - Journal of Law, Medicine and Ethics 49 (1):10-18.
    Current debates about the roles of the public and private sectors in pharmaceutical innovation have a long history. The extent to which, and ways in which, the public sector supports drug innovation has implications for assessments of the returns to public research funding, taxpayer rights in drugs, the argument the high prices are needed to support drug innovation, and the desirability of patenting publicly funded research.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  18.  1
    INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development — Historical Scope, Opportunities, and Challenges.Ameet Sarpatwari & Aaron S. Kesselheim - 2021 - Journal of Law, Medicine and Ethics 49 (1):6-9.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  19. Soft Law Possibilities in Global Health Law.Sharifah Sekalala & Haleema Masud - 2021 - Journal of Law, Medicine and Ethics 49 (1):152-155.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  20. From Exceptionalism to Essentialism in Dentistry.Lisa Simon - 2021 - Journal of Law, Medicine and Ethics 49 (1):89-91.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  21. Ethical Allocation of Scarce Food Resources During Public Health Emergencies.Sarah Wetter, James G. Hodge & Emily Carey - 2021 - Journal of Law, Medicine and Ethics 49 (1):132-138.
    Escalating demands for limited food supplies at America’s food banks and pantries during the COVID-19 pandemic have raised ethical concerns underlying “first-come, first-served” distributions strategies. A series of model ethical principles are designed to guide ethical allocations of these resources to assure greater access among persons facing food insecurity.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
 Previous issues
  
Next issues